Current Market Conditions and Key Features
1. Substantial Growth Driven by Healthcare Investment:
Market Size: China is the fastest-growing endoscopy market in the Asia-Pacific region and is expected to continue its double-digit growth. This growth is driven by China's large population base, aging population, and rising incidence of gastrointestinal cancers (gastric and colorectal cancers are prevalent in China).
Healthcare Expansion: The Chinese government continues to expand healthcare coverage under its universal basic medical insurance system, significantly improving patient access to diagnostic and treatment procedures, including endoscopy.
2. Government Policy as a Key Market Driver:
Volume-Based Procurement (VBP): This is currently the most powerful force influencing the market. The government negotiates large-scale purchases of medical devices in exchange for significant price reductions. This policy severely suppresses pricing from international brands and provides a significant advantage to cost-competitive domestic manufacturers.
"Domestic First" Policy: Government directives and hospital procurement rules generally favor domestic products, especially in public tenders. The explicit purpose of this policy is to promote the development of the domestic medical technology industry and achieve import substitution.
Stricter Infection Control Regulations: Recent high-profile incidents related to endoscope reprocessing have prompted the National Health Commission (NHC) to introduce stricter regulations. This has increased the operational costs of using reusable endoscopes (e.g., chemicals, labor, and tracking costs) and is a key driver of the market for single-use endoscope replacements.
3. Technological Transition:
The shift to video endoscopes: The market is rapidly shifting from fiberoptic endoscopes to video endoscopes, which offer superior image quality. This is a key area of competition for domestic companies.
Advanced Imaging: Technologies such as narrow-band imaging (NBI), autofluorescence imaging (AFI), and confocal laser microendoscopy are becoming increasingly common in high-end hospitals, but these technologies are still primarily provided by international manufacturers.
Market Challenges
High Cost of Ownership: While reusable endoscopes carry a high purchase price, hospitals also incur high subsequent processing costs (including personnel, space, disinfectants, and water), as well as repair/maintenance costs (which are notoriously expensive, especially for international brands).
Reprocessing and Infection Control: Ensuring that every reusable endoscope is perfectly reprocessed is a significant challenge, posing a risk of hospital-acquired infections (HAIs). This is a persistent concern for hospital administrators.
Tiered Diagnosis and Treatment System: The market is highly segmented. Top hospitals in megacities (such as Beijing and Shanghai) require the latest high-end technology (often from international brands), while county-level and rural hospitals are highly price-sensitive and are the primary target customers for domestic manufacturers.
Zhuji Pengtian Medical Equipment Co., Ltd. is a national high-tech enterprise integrating the research and development, production, sales and international trade of gastroenterology and gynecology equipment. Manufacturer of high-tech medical equipment.
Founded in 2003, the company is located in the beautiful hometown of Xishi - Zhuji, with a number of modern production plants. After years of development, it has a mature sales network in the domestic market, and has formed a wide range of market coverage. It has also established a solid overseas market in Europe, America, Southeast Asia and other regions. Keep improving product quality and perfect service for us to win the praise of every customer.
Scientific management, advanced technology, excellent equipment and nearly 20 years of production experience ensure product quality. Many products have obtained CE, FDA, ISO 13485 and other international medical device quality system certifications, and NMPA medical device registration certificates. There are still nearly 20 products under registration and research and development. The company has dozens of invention and utility model patents, including 1 domestic invention patent, 1 Korean and European invention patent, nearly 50 valid utility model patents, and many patents are in the acceptance stage.
Our company advocates the corporate culture of people-oriented, respecting the virtuous and valuing officials, and hopes to develop and progress together with the employees.
